Identification of IFN-γ-Producing Cells in IL-12/IL-18-Treated Mice
1999
Abstract Both IL-12 and IL-18 have been characterized as effective IFN-γ-inducing cytokines. Concomitant treatment with IL-12 and IL-18 has been shown to synergistically induce IFN-γ and may be an effective therapy for treating cancer, allergy, and infectious diseases. To understand the mechanisms underlying the strong induction of IFN-γ by IL-12/IL-18 in mice, we focused our studies on the IFN-γ-producing cells in various lymphoid organs and tissues and utilized the intracellular cytokine staining method to detect such cells in situ. After combined treatment with IL-12 and IL-18, IFN-γ-positive cells in C57BL/6 mice were detected in the liver (12.18%), spleen (0.68%), bone marrow (1.80%), and peritoneum (2.12%), but not in the thymus or lymph nodes ( + cells, while those in the spleen were mostly CD3 + cells, and to a lesser degree NK1.1 + cells. Both CD4 + and CD8 + cells in the liver and in the spleen produced IFN-γ. The CD19 + B cell population was not definitely shown to produce IFN-γ in our induction experiments. NKT cells, which are a subpopulation of NK1.1 + CD3 + cells, were diminished in the liver and did not seem to contribute to IFN-γ production arising from IL-12/IL-18 treatment. Further in vitro experiments confirmed the responsiveness of hepatic mononuclear cells to IL-12/IL-18 stimulation. This study is the first to show the IFN-γ-producing mechanisms of IL-12/IL-18 treatment at the phenotypic level.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
73
Citations
NaN
KQI